AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

1.93
Delayed Data
As of Dec 08
 +0.03 / +1.58%
Today’s Change
1.76
Today|||52-Week Range
13.00
-82.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues19.3M17.4M8.0M2.2M
 
 
 
 
 
Cost of Goods Sold778.0K10.3M8.9M3.4M
 
 
 
 
 
Depreciation And Amortization2.0M2.1M1.7M575.0K
 
 
 
 
 
 
Operating ExpensesGross Income16.5M5.0M-2.7M-1.8M
 
 
 
 
 
General Expenses35.7M37.0M36.0M33.9M
 
 
 
 
 
Research And Development22.5M21.4M19.4M13.1M
 
 
 
 
 
Total Operating Expenses38.5M49.3M46.7M37.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.2M-32.0M-38.7M-35.7M
 
 
 
 
 
Extraordinary Credit2.1M600.0K95.0K86.0K
 
 
 
 
 
Extraordinary Charge-756.0K0.000.000.00
 
 
Interest Expense On Debt5.4M12.2M14.0M12.6M
 
 
 
 
 
Other Expenses-380.0K318.0K415.0K1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.6M-43.2M-52.2M-47.1M
 
 
 
 
 
Income Taxes-760.0K-34.0K-701.0K-2.0K
 
 
 
 
 
Net Income-24.4M-43.2M-51.5M-47.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.3M45.3M46.9M58.4M
 
 
 
 
 
Shares To Calculate EPS Diluted44.5M45.3M46.9M58.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.60-$0.95-$1.10-$0.81
 
 
 
 
 
EPS Diluted-$0.60-$0.95-$1.10-$0.81